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The present experiment was conducted to study the eﬀect of ethanolic extract of Egyptian propolis given alone or in combination
with inactivated Pasteurella multocida vaccine on rabbits challenged with a virulent strain of Pasteurella multocida. Fifty-six New-
Zealand rabbits, 6–8 weeks old and non-vaccinated against pasteurellosis, were randomly divided into eight equal groups. The ﬁrst
group was kept as a control for the experiment. The other groups received diﬀerent treatments with propolis extract, inactivated
vaccine, or both. The experiment continued for seven weeks during which clinical signs, body weight, and mortality rate were
monitored, and blood samples were collected weekly for evaluating the leukogram, serum biochemistry, and immune response in
all groups of animals. At the end of the seventh week, the animals were subjected to challenge with a virulent strain of Pasteurella
multocida. Two weeks later, tissue specimens were collected from diﬀerent organs for histopathological examination. Results
showed that rabbits of the groups treated with both propolis and the vaccine by diﬀerent routes appeared healthy after challenge. It
has been concluded that alcoholic extract of propolis administrated in combination with inactivated Pasteurella multocida vaccine
has no adverse eﬀects on the general health conditions and enhances immune response in rabbits.
1.Introduction
Rabbits are considered one of the important livestock that
provide high quality protein food. One of the important
diseases that aﬀect rabbits’ production is pasteurellosis. It is
a common bacterial disease caused by Pasteurella multocida
and has been reported as a constant serious and highly
contagious disease of domestic rabbits [1]. Pasteurellosis
aﬀects rabbits of 4–8 weeks old causing symptoms ranging
from fatal septicemia, severe pleuritis, and pneumonia to less
severe sequelae such as multiple abscesses, chronic rhinitis,
and otitis media. The outcome of any form of the disease is
severe economic losses [2].
Control of pasteurellosis in rabbits is accomplished by
vaccination against Pasteurella multocida infection. Protec-
tive immunity can be induced by a live vaccine or an
inactivatedwholecellvaccine(bactrine).Thelivevaccinehas
advantage over the bactrine, though a serious disadvantage
is that vaccination with living vaccines, sometimes, results in
systemic infection. On the other hand, vaccination of rabbits
with bactrines often results in ineﬀective immunity in the
ﬁeld [3].
Propolis (bee glue) is a resinous hive product, produced
by honey bees from various plant sources. It has several bi-
ological properties as antimicrobial, antiinﬂammatory, im-
munomodulatory, and antioxidant [4–6]. It have been used
since ancient times as a medicine because of its biological
properties as antiinﬂammatory, antiallergic properties, anti-
carcinogenic, antioxidative, antifungal, antiviral, immunos-
timulant, and for tissue regeneration [7–9]. Administration
of propolis alleviated the harmful eﬀects of insecticide,
propetamphos [10]. Caﬀeic acid phenethyl ester (CAPE) is
the active component of propolis [11].
The aim of the present study was to evaluate the eﬀect
of an extract of Egyptian propolis when administrated either
orally or by the subcutaneous (S/C) route with inactivated
Pasteurella multocida vaccine against experimental challenge
with Pasteurella multocida strain in rabbits. General per-
formance, leukogram, serum biochemical parameters, and2 The Scientiﬁc World Journal
immunological status of rabbits were investigated. Two
weeks later from challenge, postmortem examination was
performed on target organs.
2.MaterialsandMethods
This study was carried out according to guidelines for animal
experimentation and approved by the Institutional Animal
Care and Use Committee, National Research Centre Animal
Care Unit, Dokki, Giza, Egypt.
2.1. Animal Used. Fifty-six male New-Zealand rabbits of
1.5-2kg body weight (B.W.) and 6–8 weeks old were
used for the purpose of the present experiment. Rabbits
were not previously vaccinated against pasteurellosis, and
bacteriological examination of nasopharyngeal swabs proved
that they were free from Pasteurella infection.
2.2. Propolis Extraction. One hundred grams of the resinous
material of Egyptian propolis (obtained from Dakahlia
Governorate, Egypt) was cut into small pieces and extracted
at room temperature with 50mL of 70% ethanol. Extraction
was performed twice with 24hours interval. The alcoholic
extract was evaporated under vacuum at 50◦C until dryness.
Obtained dried ethanolic extract of propolis (28g) was
suspended in phosphate buﬀered saline (PBS) (pH 7.2) to
obtain 1% stock solution [12]. The dose of propolis used in
this experiment was 50mg/kg B.W. according to T¨ urkez et al.
[13].
2.3. General Layout of the Experiment. The experiment was
carried out at the experimental rabbit unit of Lab Ani-
mal House, National Research Center, Dokki, Giza, Egypt.
Rabbits were housed in separate cages, fed on a balanced
commercial ration and water was available ad libitum.
The animals were assigned into eight equal groups which
were treated with alcoholic extract of propolis alone or in
combination with Pasteurella multocida inactivated vaccine
(obtained from Veterinary Serum and Vaccine Research
Institute, Abbasia, Cairo). Propolis was administrated either
orally (50mg/kg B.W./day for one week), or by the subcu-
taneous (S/C) route (a single dose of 50mg/kg B.W.). The
vaccine was given as a single S/C dose of 2mL. Treatment
of diﬀe r e n tg r o u p so fr a b b i t sw a sa sf o l l o w s :g r o u p( 1 )
injected subcutaneously with 2mL sterile PBS and was
kept as control, group (2) administrated propolis orally,
group (3) administrated propolis orally then vaccinated
with Pasteurella multocida vaccine, group (4) was vaccinated
then after one week administrated propolis orally, group (5)
was simultaneously vaccinated and administrated propolis
orally, group (6) was vaccinated only, group (7) was injected
subcutaneously with the vaccine mixed with propolis as an
adjuvant, and group (8) was injected subcutaneously with a
single dose of propolis. Treatments of propolis and vaccine
were repeated after four weeks in all groups. The experiment
continued for seven weeks, at the end of which challenge
wasperformedbyinjectionwithvirulentstrainofPasteurella
multocida. The strain was obtained from Veterinary Serum
and Vaccine Research Institute, Abbasia, Cairo, in the form
of lyophilized ampoules. It was activated by culturing in
nutrient broth, inoculation in Swiss mice, and reisolation
of the organism from heart blood of mice on nutrient
agar plates (Difco). Pasteurella colonies were suspended
in sterile saline and the density was adjusted to contain
5×109 bacterial cell/mL. The suspension was used for S/C
inoculation of rabbits in the challenge test [14].
2.4. Clinicopathological Investigations
2.4.1. Leukogram and Biochemical Analyses. During the
seven-week experimentation time, rabbits were weighed and
blood samples were collected weekly. Three blood samples
were obtained from the ear vein of each rabbit. The ﬁrst
sample was anticoagulated and used for the determination
of the leukogram. A Coulter counter (MEDONIC CA620)
was utilized [15]. The second sample was collected for serum
separation and determination of serum biochemical con-
stituents and serological studies. Serum biochemical assays
included total proteins [16], albumin [17], total cholesterol
[18], triglycerides [19], glucose [20], and activities of amino-
transferases (AST and ALT) [21], and alkaline phosphatase
(ALP)[22].Serumglobulinsweredeterminedbysubtracting
the value of serum albumin from the value of serum
total proteins. Commercial diagnostic kits from Biomerieux,
France, and Quimica Clinica Aplicada (QCA), Amposta,
Spain, were used for assay of serum biochemical parameters.
2.5. Immunological Studies
2.5.1. Humeral Immune Response. Serum samples were uti-
lized also for estimation of the humeral immune response
againstPasteurella multocidaantigeninrabbits.Theenzyme-
linked immunosorbant assay (ELISA) was used according
to Shu et al. [23]. A positive result was considered when
the absorbance value was equal to or more than the cut-oﬀ
value. The cut-oﬀ v a l u ee q u a l sd o u b l ef o l dt h em e a nv a l u eo f
negative sera.
2.5.2. Cellular Immune Response (Lymphocyte Proliferation
Assay (BrdU)). The third blood sample was collected in
sterile heparinized tubes from groups 1, 6, 7, and 8 at the
1st, 2nd, and 4th weeks after vaccination. Blood was used
forseparationofmononuclearleukocytesforthelymphocyte
proliferation assay (BrdU) to measure the cellular immune
response of rabbits against Pasteurella multocida. A test kit
from Roche Diagnostics, Germany, was used.
2.6. Challenge Assay. At the end of the experiment (7th
week), experimental rabbits werechallengedby S/C injection
of 0.2mL/rabbit of broth culture of virulent Pasteurella mul-
tocida. Reisolation and identiﬁcation of Pasteurella organ-
isms were done from the heart blood of rabbits died after
challenge [14].
2.7. Postmortem Examination. Two weeks later from chal-
lenge test, Postmortem investigation was performed on target
organs (heart, trachea, lungs, liver, kidneys, and spleen).The Scientiﬁc World Journal 3
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Figure 1: Heterophil (a), lymphocyte (b) counts, and serum globulins (c) in diﬀerent experimental groups of rabbits received propolis and
vaccine treatments for six weeks.
2.8. Statistical Analysis. Statistical analysis was performed on
the collected data for the mean and standard error of the
mean. Signiﬁcance of the results was determined using two-
wayanalysisof variancefollowedby Duncan’smultiple range
tests.DiﬀerenceswereconsideredsigniﬁcantatP<0.05level
[24] using SPSS version 10 computer programme.
3. Results
3.1. Clinical Signs. Rabbits of diﬀerent groups appeared nor-
mal before challenge with the virulent strain of Pasteurella
multocida. One day after challenge, rabbits of the control
group (group 1) showed acute signs of the disease in the
formofdepression,sneezing,andrespiratorymanifestations.
Some rabbits showed nervous manifestations and sudden
death. Mortality rate in this group reached 100%. Rabbits
treated with either propolis or the vaccine only (groups 2,
6, and 8) showed less severe clinical signs than the control
group. Some rabbits of group (6) which received the vaccine
only showed superﬁcial multiple abscesses (the chronic form
of the disease). Mortality rate was 57.14% in groups 2 and 8
and 28.57% in group 6. Rabbits treated with both propolis
and the vaccine by diﬀerent regimens (groups 3, 4, 5, and
7) were apparently healthy and showed no mortalities after
challenge. Body weight of diﬀerent experimental groups did
not change signiﬁcantly compared to control group.
3.2. Leukogram. Total leukocytes’ count was elevated in all
experimental groups except group 8 (received S/C propolis
only) compared to control group. Elevation of total leuko-
cytes was associated with elevation of lymphocytes and
heterophils (Table 1, Figures 1(a) and 1(b)). Monocytes and
eosinophilsrevealedvariablechangesindiﬀerentexperimen-
tal groups.4 The Scientiﬁc World Journal
Table 1: Total leukocytes count (×103/μL) in diﬀerent experimental groups of rabbits received propolis and vaccine treatments for six weeks
(mean ± SE).
Groups
Period
(week)
Control
(1)
Propolis orally
(2)
Propolis orally
then vaccine
S/C
(3)
Vaccine S/C
then propolis
orally
(4)
Propolis orally
+ vaccine S/C
(5)
Vaccine S/C
only
(6)
Propolis +
vaccine S/C
(7)
Propolis S/C
(8)
1 8.85bd
±0.55
7.98d
±0.40
8.93bd
±0.52
9.60bc
±0.51
8.24cd
±0.13
9.68b
±0.45
12.50a
±0.31
9.82b
±0.45
2 8.42bc
±0.57
9.10bc
±0.76
7.82c
±0.35
8.31bc
±0.37
9.80ab
±0.90
11.06a
±0.24
8.22bc
±0.28
8.14bc
±0.33
3 8.89b
±0.61
11.60a
±0.56
12.43a
±0.78
12.95a
±0.37
11.50a
±0.48
8.96b
±0.23
12.78a
±0.25
9.28b
±0.30
4 10.32c
±0.27
11.12bc
±1.28
13.66a
±0.76
13.18ab
±0.41
10.35c
±0.39
12.28a−c
±0.56
13.37a
±0.35
12.44a−c
±0.78
5 8.57e
±0.24
12.56b
±0.25
14.18a
±0.62
12.12bc
±0.45
10.44d
±0.42
11.18cd
±0.32
12.78b
±0.40
11.36cd
±0.27
6 9.90c
±1.22
12.36b
±0.33
16.54a
±0.41
12.84b
±0.49
12.40b
±0.73
8.65c
±0.23
12.86b
±0.82
10.34c
±0.39
Means followed by diﬀerent superscripts (a, b, c, d, e) within the same row are signiﬁcantly diﬀerent at P<0.05.
SE: standard error.
Table 2: Serum total proteins (g/dL) in diﬀerent experimental groups of rabbits received propolis and vaccine treatments for six weeks
(mean ± SE).
Groups
Period
(week)
Control
(1)
Propolis orally
(2)
Propolis orally
then vaccine
S/C
(3)
Vaccine S/C
then propolis
orally
(4)
Propolis orally
+ vaccine S/C
(5)
Vaccine S/C
only
(6)
Propolis +
vaccine S/C
(7)
Propolis S/C
(8)
1 7.23b−c
±0.30
6.95bc
±0.91
6.23c
±0.39
6.91bc
±0.64
7.02bc
±0.46
7.52b
±0.30
8.51a
±0.39
8.77a
±0.20
2 6.32c
±0.44
7.04bc
±0.70
7.43bc
±0.34
7.40bc
±0.19
7.35bc
±0.14
6.97c
±0.38
9.45a
±0.65
7.98b
±0.12
3 5.34d
±0.28
5.19cd
±0.91
7.32a−c
±0.60
7.16bc
±0.22
6.57cd
±0.30
8.11a
±0.20
8.88a
±0.46
7.79ab
±0.17
4 4.99d
±0.31
7.11bc
±0.19
6.15c
±0.49
6.72c
±0.23
7.66b
±0.16
6.32c
±0.10
9.20a
±0.53
8.19b
±0.41
5 4.95d
±0.25
7.96bc
±0.26
7.13bc
±0.32
7.02bc
±0.23
8.93a
±0.28
8.64ab
±0.38
9.35a
±0.20
8.40b
±0.03
6 5.15c
±0.31
8.21a
±0.03
5.23c
±0.10
6.27bc
±0.12
6.21bc
±0.30
8.59a
±0.53
8.52a
±0.35
7.49b
±0.17
Means followed by diﬀerent superscripts (a, b, c, d, e) within the same row are signiﬁcantly diﬀerent at P<0.05.
SE: standard error.
3.3. Biochemical Changes. Values of serum total protein were
elevatedingroups7and8(receivedS/Cpropolisonlyorwith
the vaccine) throughout the experimentation time. Values
were elevated in the other groups at diﬀerent times between
the 3rd and 6th week of the experiment. Serum globulin
values were elevated in all vaccinated groups (4, 5, 6, and
7) and in the group treated with propolis subcutaneously
(8th group) from the 2nd to the 6th week of the experiment
(Table 2, Figure 1(c)).
Serum glucose values were decreased starting from the
1st or 2nd week to the end of the experiment in all groups
received propolis in their treatment. The decrease was from
the 4th week to the end of the experiment in the group
received the vaccine only (group 6) (Figure 2(a)).
Cholesterol values were decreased from the 2nd to the
6th week of the experiment in groups 2, 3, 4, and 5, and at
diﬀerent times of the experiment in groups 6, 7 and 8. Values
of triglycerides were decreased from the 4th to the 6th week
in all experimental groups (Figures 2(b) and 2(c)).
Activity of serum enzymes was decreased in diﬀerent
experimental groups. AST and ALT activity was elevated in
groups 6 and 7, respectively, between the 2nd and 4th week
of the experiment. In the other groups AST, and ALT activity
was elevated occasionally. Changes in ALP activity were less
marked in diﬀerent experimental groups.
3.4. Immunological Results. Examination of the humeral im-
mune response of rabbits by the enzyme-linked immunosor-
bant assay (ELISA) revealed elevation of serum antibodies in
all groups, but group 2 and 8 received propolis by the oral or
theS/Croute,fromthe2ndtothe7thweekoftheexperiment
(Table 3).The Scientiﬁc World Journal 5
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Figure 2: Serum glucose (a), total cholesterol (b), and triglycerides (c) in diﬀerent experimental groups of rabbits received propolis and
vaccine treatments for six weeks.
Table 3: Enzyme-linked immunosorbant assay (ELISA) in diﬀerent experimental groups of rabbits received propolis and vaccine treatments
from the second till the seven week (mean ± SE).
Groups
Period
(week)
Control
(1)
Propolis orally
(2)
Propolis orally
then vaccine
S/C
(3)
Vaccine S/C
then propolis
orally
(4)
Propolis orally
+ vaccine S/C
(5)
Vaccine S/C
only
(6)
Propolis +
vaccine S/C
(7)
Propolis S/C
(8)
2 0.136
±0.01
0.124
±0.04
0.504
±0.02
0.502
±0.05
0.518
±0.03
0.531
±0.06
0.522
±0.05
0.144
±0.01
3 0.131
±0.00
0.118
±0.03
0.412
±0.03
0.532
±0.00
0.464
±0.01
0.493
±0.01
0.441
±0.04
0.126
±0.04
4 0.149
±0.00
0.201
±0.02
0.350
±0.02
0.371
±0.01
0.494
±0.07
0.285
±0.01
0.421
±0.03
0.152
±0.01
5 0.154
±0.01
0.144
±0.01
0.344
±0.01
0.516
±0.03
0.483
±0.00
0.353
±0.03
0.455
±0.01
0.154
±0.03
6 0.151
±0.00
0.127
±0.00
0.361
±0.02
0.409
±0.02
0.561
±0.01
0.402
±0.03
0.533
±0.04
0.149
±0.02
7 0.135
±0.01
0.150
±0.00
0.403
±0.02
0.463
±0.02
0.408
±0.01
0.471
±0.01
0.414
±0.02
0.138
±0.01
Cut-oﬀ
value
0.2906 The Scientiﬁc World Journal
Table 4: Lymphocyte proliferation assay (BrdU) in diﬀerent experimental groups of rabbits received propolis and vaccine treatments for six
weeks (mean ± SE).
Groups
Period
(week)
Control
(1)
Vaccine S/C
only
(6)
Propolis +
vaccine S/C
(7)
Propolis S/C
(8)
1 0.09b
±0.01
0.19a
±0.03
0.14ab
±0.02
0.10b
±0.02
2 0.10b
±0.02
0.21a
±0.06
0.23a
±0.03
0.10b
±0.03
4 0.06c
±0.03
0.26a
±0.04
0.26a
±0.02
0.14b
±0.03
Means followed by diﬀerent superscripts (a, b, c, d, e) within the same row are signiﬁcantly diﬀerent at P<0.05.
SE: standard error.
Cellular immune response measured by the lymphocyte
proliferation assay in groups 6, 7, and 8 at the end of the
1st, 2nd, and 4th weeks of the experiment revealed positive
reaction from the 1st to the 4th week in group 6 (vaccinated
group), at the 2nd and 4th weeks in group 7, and at the 4th
weekingroup8.Theresponseingroups7and8waslessthan
that in group 6 (Table 4).
3.5. Postmortem Investigations. Postmortem ﬁndings of con-
trol rabbits group challenged with Pasteurella multocida
strain showed lesions of acute pasteurellosis in the form
of severe rhinitis with nasal discharges, congested blood
vessels with S/C hemorrhage, presence of blood in the
thorax and abdomen, severe congestion of trachea, lungs
and heart, necrotic foci in the liver, and congested friable
kidneys. Rabbits of groups 2 and 8 administrated propolis
onlyshowedS/Chyperemicpatches,congestedheart,trachea
and lungs, enlarged liver with necrotic foci, congested and
enlarged spleen. Rabbits administrated the vaccine only
(group 6) showed less severe lesions of the disease repre-
sented by presence of multiple lung abscesses, congestion of
the lungs, enlarged urinary bladder which was ﬁlled with
urine and salts. Rabbits of the groups administrated propolis
and vaccine appeared normal when scariﬁed 15 days after
challenge.Some rabbits showed multiple S/C abscessesin the
front leg, and in the neck.
4. Discussion
A large body of investigators has reported on the use
of immune stimulants for enhancement of the immune
response during vaccination. Propolis is a resinous hive
product collected by honey bees from various plant sources.
It contains more than 160 constituents that have several bio-
logical and pharmacological properties such as antimicro-
bial, antiinﬂammatory, immunomodularity, and antioxidant
eﬀects [25–28].
The present work was carried out to evaluate the eﬀect
of an ethanolic extract of Egyptian propolis as immunostim-
ulant to an inactivated formalized Pasteurella multocida vac-
cine used to immunize rabbits. Propolis was administrated
either orally or by S/C injection with, or without the vaccine.
Evaluation was assessed by observation of the clinical signs,
clinicopathologicalandimmunologicalinvestigations.Atthe
end of treatment, groups of rabbits were challenged with
av i r u l e n ts t r a i no fPasteurella multocida and evaluated
by observation of the clinical signs, mortality rate, and
postmortem investigation.
Experimental rabbits appeared healthy during the time
of the experiment before challenge. Investigation of the
leukogram revealed leukocytosis in almost all experimental
groups except those treated with the vaccine (group 6) or
propolis only (group 8). Leukocytosis was associated with
heterophilia and lymphocytosis. The obtained results may
indicate an immune-stimulatory eﬀect of propolis when
combined with the vaccine [29, 30]. It has been reported that
propolis has a direct regulatory eﬀect on the basic functional
properties of immune cells [31]. Artepillin C which is one
of propolis components has been described to activate the
immune system by increasing phagocytic activity as well as
number of lymphocytes [32]. Propolis extract may increase
production of the lymphocyte activating factor IL-1 which
enhances B- and T-cell proliferation [33, 34].
Total protein values were elevated especially in groups
treated with the vaccine and propolis S/C, or propolis
S/C (groups 7 and 8, resp.). The elevation was associated
with increase of globulin values. Results pointed out to a
nonspeciﬁc immunostimulant eﬀect of propolis alone or
as adjuvant to the vaccine [34, 35] and a speciﬁc immune
response induced by Pasteurella multocida vaccine [36, 37].
Results of serum lipids revealed that the ethanolic extract
of propolis has a decreasing eﬀect on serum total cholesterol
and triglycerides which may be attributed to the presence of
ﬂavonoids, steroids, phenolic acids, and their esters among
propolis constituents [12, 38]. These compounds may aﬀect
directly lipid metabolism leading to decrease of cholesterol
andtriglyceridesinblood[39].Suchresultsareconﬁrmedby
the ﬁndings of Badawi [40]a n dA l i[ 41]. Fuliang et al. [42]
reported that oral administration of propolis signiﬁcantly
lowered total cholesterol and triglycerides in serum of rats.
Alves et al. [43] reported that the hypocholesterolemic eﬀect
of propolis could be a result of a direct eﬀect on the liver
or an indirect eﬀect through thyroid hormones which aﬀect
reactions in almost all the pathways of lipid metabolism.
Along the period of experiment, the activity of serum
enzyme AST was decreased in diﬀerent experimental groupsThe Scientiﬁc World Journal 7
except in group 6 (vaccinated group), where the elevation
was recorded during the 2nd to the 4th week of the
experiment. The present results agree with Hegazi et al. [12],
and Talas and Gulhan [38]. Badawi [40] found that admin-
istration of propolis to rats in a dose of 150–1500mg/kg
B.W. caused slight inhibition of the activity of transferase
enzymes.Ali[41]reportednoapparentchangeinserumAST
activity due to single dose of propolis (100mg) in rats. The
result of the present study indicated that administration of
propolis had no toxic eﬀect on rabbits. Activity of serum
ALT followed a similar pattern to that of AST. Similar results
were observed by Kleinrok et al. [44] and Eraslan et al.
[39]. Oliveira et al. [45], on the other hand, reported that
crude propolis extract did not cause signiﬁcant alterations in
the serum enzymes alanine and aspartate aminotransferase
activities.
Results of serum ALP activity revealed signiﬁcant
decrease in groups 2 through 6 during the period from the
1st to the 3rd week of the experiment which may be due to
the action of propolis as reducing agent to ALP. The present
results agree with Hegazi et al. [12].
Values of serum glucose were decreased in all groups
administrated propolis. It has been described that this
decrease was related to inhibition of the activity of intestinal
maltase by propolis [39].
The ELISA positive titer of Pasteurella multocida anti-
bodies in group 6 (vaccinated only) agrees with Borkowska
et al. [36, 37]. Antibody titers in groups treated with the
vaccine and propolis by diﬀerent routes were higher than
that of the vaccinated group and may be attributed to the
ability of propolis for modulating the synthesis of antibodies
[46]. Previous reports stated that the ethanolic extract of
propolis increased antibody production [33] and has potent
eﬀect on diﬀerent cells of innate immune response [47].
CAPI which is one of propolis components increase T-
lymphocyte proliferation as well as secretion of IL-1 and IL-
2b ys p l e n o c y t e s[ 48]. Chu [34] mentioned that propolis
could activate antigen presenting cells (e.g., macrophages)
to produce cytokines which activate T and B lymphocytes.
Ansorge et al. [31] and Cuesta et al. [49] were of the opinion
that propolis stimulated nonspeciﬁc and speciﬁc immunity
factors.
Positive titers of lymphocyte proliferation were only
recorded at the 2nd and 4th weeks in groups 6 and 7. This
result may be attributed to that inactivated vaccine enhances
mainlyhumeralimmuneresponseandspeciallyIgG[50,51].
The weak eﬀect of propolis on lymphocyte proliferation
may be related to the inhibitory eﬀect of CAPI on some
transcription factors [52]. Similar ﬁndings were previously
reported by Hu et al. [53] and Paulino et al. [54].
In conclusion, the ethanolic extract of Egyptian propolis,
when administrated in combination with formalized inac-
tivated Pasteurella multocida vaccine in rabbits’ enhanced
speciﬁc and nonspeciﬁc immune response, revealed no toxic
eﬀect and reduced the severity of adverse clinical signs, and
mortality rate. The present experimental trial can encourage
the use of propolis as an immunostimulant with human and
animal vaccines.
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